help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 13, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1814
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/2/597    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Short, K. R.
Right arrow Articles by Nair, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Short, K. R.
Right arrow Articles by Nair, K. S.
Related Collections
Right arrow Metabolism
Right arrow Neuroendocrinology and Pituitary

Submitted on August 14, 2007
Accepted on November 5, 2007

Enhancement of Muscle Mitochondrial Function by Growth Hormone

Kevin R. Short, Niels Moller, Maureen L. Bigelow, Jill Coenen-Schimke, and K. Sreekumaran Nair*

Endocrinology Research Unit, Mayo Clinic School of Medicine, Rochester, MN 55905, USA

* To whom correspondence should be addressed. E-mail: nair.sree{at}mayo.edu.

Context: Though growth hormone (GH) promotes growth and protein anabolism, which are ATP-dependent processes, the GH effect on mitochondrial regulation remains to be determined.

Objective: To determine the acute effect of GH on mitochondrial oxidative capacity in skeletal muscle of healthy subjects

Design: A randomized crossover design was used.

Setting: Academic medical center.

Participants: Nine healthy men and women completed the study.

Intervention: GH (150µg/hr) or saline was infused for 14 h on separate days and muscle biopsies were obtained.

Main Outcome Measures: Mitochondrial function, gene expression and protein metabolism.

Results: The 4-fold increase in plasma GH caused elevations in plasma IGF-I, insulin, glucose, and free fatty acids, and a shift in fuel selection, with less carbohydrate (-69%) and leucine (-43%) oxidation and 29% more fat oxidation. Muscle mitochondrial ATP production rate and citrate synthase activity were increased 16–35% in response to GH. GH also resulted in higher abundance of muscle mRNAs encoding IGF-I, mitochondrial proteins from the nuclear (COX4) and mitochondrial (COX3) genomes, the nuclear-derived mitochondrial transcription factor A (TFAM), and glucose transporter 4. While GH increased whole body protein synthesis (non-oxidative disposal of leucine), no effect on synthesis rate of muscle mitochondrial proteins was observed.

Conclusions: These results demonstrate that acute GH action promotes an increase in mitochondrial oxidative capacity and abundance of a several mitochondrial genes. These events may occur through direct or indirect effects of GH on intracellular signaling pathways, but do not appear to involve a change in mitochondrial protein synthesis rate.


Key words: ATP production • citrate synthase • mRNA • transcription factors • protein synthesis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society